Employees
717
Industry
Biological Product (except Diagnostic) Manufacturing
freeline is a biopharmaceutical company focused on the development and commercialisation of gene therapies for bleeding and other debilitating disorders based on a next-generation aav gene therapy platform developed by amit nathwani, professor of haematology at ucl and cso of freeline therapeutics http://www.freelinetx.com
Loading...
Open
6.49
Mkt cap
28M
Volume
5.3K
High
6.49
P/E Ratio
-0.57
52-wk high
8.74
Low
6.48
Div yield
N/A
52-wk low
2.11
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.